HBOT Indications: Evidence and Approval Status

Hyperbaric oxygen therapy, often called HBOT or HBO2, is used in a defined group of clinical situations and is also the subject of research across many others. Those categories should not be treated as interchangeable. An established indication, a condition with limited evidence, and a wellness claim can each involve very different evidence, clinical protocols, device requirements, and decisions about whether treatment is appropriate.

This reference groups commonly discussed indications by the strength and nature of the available support. It is educational only. It does not diagnose, recommend treatment, or determine whether HBOT is suitable for any individual. Decisions about care belong with appropriately qualified medical professionals who can consider the full clinical picture.

How to read this reference

The terms used in HBOT discussions can be confusing because professional guidance, device clearance, reimbursement rules, and local clinical practice do not always use identical language. A condition may be recognised in one framework, considered in selected circumstances, or still be under investigation.

For clarity, this article uses three broad categories:

• Established clinical indications are conditions for which HBOT is widely recognised within major hyperbaric medicine frameworks or used in defined clinical circumstances.
• Limited or evolving evidence describes conditions where research, selected protocols, or professional discussion exists, but the evidence base or routine clinical use remains limited.
• Investigational or unsupported uses describes conditions and wellness claims that should not be presented as established HBOT indications.

Coverage and access decisions are separate from clinical evidence. They can vary by payer, facility, device, protocol, and the facts of an individual case. A list like this is not a substitute for a clinical assessment.

Infections and radiation related tissue injury

Several established HBOT indications relate to severe infection or tissue injury after radiation exposure. These are generally managed in clinical settings with protocols designed for the underlying condition.

Established or recognised clinical uses

• Clostridial myonecrosis, sometimes called gas gangrene
• Necrotising soft tissue infection in appropriate clinical circumstances
• Refractory osteomyelitis
• Osteoradionecrosis
• Soft tissue radionecrosis
• Actinomycosis in selected circumstances

Radiation related tissue injury is sometimes discussed alongside cancer care. That distinction matters. HBOT may be considered for specific late effects of radiation, such as osteoradionecrosis or soft tissue radionecrosis. It should not be described as a general cancer treatment or as a replacement for oncology care.

Conditions without established status

Chronic sinusitis, non clostridial systemic infection, general aerobic infection, and broad claims about septic illness are not established HBOT indications. Severe infections require urgent medical evaluation and condition specific treatment.

Circulatory and vascular conditions

HBOT is sometimes considered where tissue oxygen delivery is compromised, but the clinical context is essential. The presence of a vascular condition alone does not establish that HBOT is appropriate.

Established or recognised clinical uses

• Acute peripheral arterial insufficiency in selected circumstances
• Advanced diabetic foot wounds when clinical criteria are met
• Severe anaemia when transfusion is not available or cannot be used

Conditions with limited or unsupported status

Arthritis, chronic fatigue syndrome, chronic pain syndrome, pancreatitis, mitochondrial disease, complex regional pain syndrome, peripheral arterial disease, peripheral neuropathy, chronic peripheral vascular insufficiency, and chronic skin ulcers are often discussed online. They should not be represented as established HBOT indications without careful condition specific evidence and clinical context.

Toxic exposures and poisoning

Some acute toxic exposures are well known reasons for urgent hyperbaric evaluation. Timing, severity, symptoms, and the treating team's assessment are central to these decisions.

Established or recognised clinical uses

• Carbon monoxide poisoning
• Cyanide poisoning in appropriate circumstances
• Smoke inhalation when carbon monoxide or cyanide exposure is a concern

Investigational or unsupported uses

Post viral symptoms, including long COVID, Lyme disease, toxic mould exposure, sepsis, hepatic necrosis, and general septicemia are not established HBOT indications. Research interest does not establish effectiveness, safety, or suitability for a particular person.

Trauma, injury, and surgical tissue compromise

HBOT has established roles in several urgent injury related situations, particularly where blood flow, tissue viability, or gas exposure is involved.

Established or recognised clinical uses

• Air or gas embolism
• Crush injury, compartment syndrome, and other acute traumatic ischemia
• Decompression sickness
• Compromised skin grafts and flaps
• Thermal burns in appropriate clinical circumstances

Conditions without established status

Bone fractures, tendon and ligament injuries, athletic recovery, organ preservation, organ storage, and cosmetic surgery recovery are not established general indications. A claim that HBOT will accelerate recovery, reduce bruising, or improve performance should be treated cautiously unless it is tied to a specific clinical indication and an appropriate evidence base.

Hearing, neurological, and vision related conditions

Neurological conditions are among the most frequently discussed areas of HBOT research and marketing. They also require particular care because symptoms can have many causes and may need urgent assessment.

Established or recognised clinical uses

• Idiopathic sudden sensorineural hearing loss in selected clinical protocols
• Intracranial abscess
• Central retinal artery occlusion in selected emergency circumstances

Limited or evolving evidence

Research and selected clinical discussion may exist for cerebral palsy, autism spectrum disorder, migraine, multiple sclerosis, tinnitus, post traumatic stress disorder, stroke recovery, traumatic brain injury, mild cognitive impairment, Bell's palsy, and other neurological conditions. This does not make them established indications. Evidence quality, study design, protocol differences, and patient selection all matter.

Conditions not established as routine indications

Fibromyalgia, Alzheimer's disease, Parkinson's disease, general cognitive decline, chronic cerebral vascular insufficiency, cerebral edema outside defined clinical contexts, and nonvascular chronic brain syndromes should not be presented as established HBOT uses.

Autoimmune, inflammatory, and chronic conditions

Chronic inflammatory and autoimmune conditions are often included in broad online lists. The existence of inflammation does not create a general indication for HBOT.

Conditions such as Crohn's disease, ulcerative colitis, irritable bowel syndrome, eczema, psoriasis, scleroderma, rheumatoid arthritis, interstitial cystitis, shingles, and general inflammation are not established broad indications. Some areas may be the subject of early research or selected clinical discussion, but that is different from routine clinical use.

Reproductive health and sexual health

Erectile dysfunction and fertility are frequently mentioned in wellness marketing. They are not established HBOT indications. These concerns can have complex medical, hormonal, vascular, psychological, and lifestyle contributors that deserve appropriate evaluation.

Mental health, fatigue, sleep, and stress

Claims about mood, anxiety, depression, attention, burnout, sleep quality, jet lag, and emotional resilience are common in consumer facing HBOT content. Current research in these areas is preliminary or mixed, and these conditions are not established general indications for HBOT.

Mental health symptoms, sleep disorders, and persistent fatigue should be assessed through appropriate clinical channels. HBOT should not be framed as a replacement for evidence based mental health, sleep, or medical care.

Cognitive enhancement, learning, and longevity claims

HBOT is sometimes promoted for focus, memory, reaction time, neuroplasticity, anti aging, telomere length, cellular repair, immune support, and general biohacking. These claims go beyond established clinical indications.

Early research, animal studies, small studies, and theoretical mechanisms can be useful starting points for scientific questions. They do not establish a treatment outcome, a performance benefit, or a longevity effect. Claims about intelligence, exam performance, memory athletics, or general cognitive enhancement should be treated as investigational rather than proven.

Regenerative, aesthetic, dental, and wellness claims

Interest also exists around stem cell mobilisation, skin appearance, collagen, hair growth, oral surgery recovery, gum disease, and general health maintenance. These areas should be described carefully.

HBOT is not an established general treatment for aesthetic goals, hair growth, immune enhancement, routine dental disease, or broad wellness optimisation. Where tissue healing is discussed, the underlying diagnosis and clinical indication remain the key considerations.

Questions to bring to a clinical discussion

If HBOT is being considered, useful questions may include:

• What is the specific diagnosis or clinical problem being addressed?
• Is HBOT being considered for an established indication, a selected protocol, or an investigational purpose?
• What evidence supports the proposed protocol for this situation?
• What alternatives, risks, and practical requirements should be considered?
• What type of chamber and level of clinical oversight are appropriate?
• How will progress, adverse effects, and changes in the care plan be monitored?

The key distinction

HBOT has important established uses in hyperbaric medicine, particularly in defined acute, infectious, radiation related, and tissue compromise scenarios. It is also an active area of research. Those two facts can coexist without turning every researched, anecdotal, or wellness related claim into an established indication.

A careful approach starts with the diagnosis, the evidence, the treatment setting, and the judgement of qualified medical professionals. That is the most reliable way to separate a meaningful clinical discussion from a broad claim that goes further than the evidence supports.